Paris, March 1, 2023
A graduate of the Ecole Supérieure de Chimie Industrielle de Lyon and EM Lyon, Rodolphe BESSERVE worked as a financial market analyst covering the health sector for ten years at Bryan Garnier, Kepler Chevreux and Société Générale.
Rodolphe then became responsible for the ECM/M&A activity for the biotech/medtech sector at Societe Generale, where he led around sixty operations (IPO, listed/unlisted fundraising, mergers, disposals, etc.).
Rodolphe then developed and managed eureKARE, an investment company in the biotech sector, for which he raised €50M from family offices. He is the initiator, co-founder and sponsor of eureKING, the first SPAC Santé in France dedicated to bioproduction, which raised €150M on Euronext in May 2022.
|